Published in Infect Immun on October 01, 1996
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol (2000) 3.77
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol (2008) 2.71
Construction and evaluation of plasmid vectors optimized for constitutive and regulated gene expression in Burkholderia cepacia complex isolates. Appl Environ Microbiol (2002) 2.07
Invasion and intracellular survival of Burkholderia cepacia. Infect Immun (2000) 1.74
Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun (2004) 1.57
Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun (1998) 1.47
Role of flagella in host cell invasion by Burkholderia cepacia. Infect Immun (2002) 1.46
Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic (2005) 1.35
Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. Infect Immun (2004) 1.30
Identification of specific and universal virulence factors in Burkholderia cenocepacia strains by using multiple infection hosts. Infect Immun (2009) 1.27
Responses of well-differentiated airway epithelial cell cultures from healthy donors and patients with cystic fibrosis to Burkholderia cenocepacia infection. Infect Immun (2004) 1.25
Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infect Immun (2010) 1.25
The mgtC gene of Burkholderia cenocepacia is required for growth under magnesium limitation conditions and intracellular survival in macrophages. Infect Immun (2006) 1.22
Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia. Infect Immun (2002) 1.21
Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis. J Bacteriol (2005) 1.20
Invasion of spores of the arbuscular mycorrhizal fungus Gigaspora decipiens by Burkholderia spp. Appl Environ Microbiol (2003) 1.20
Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice. Infect Immun (2001) 1.19
Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun (2003) 1.15
Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay. Appl Environ Microbiol (2010) 1.14
Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection. Infect Immun (2002) 1.13
Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection. Infect Immun (2002) 1.07
The posttranscriptional regulator RsmA plays a role in the interaction between Pseudomonas aeruginosa and human airway epithelial cells by positively regulating the type III secretion system. Infect Immun (2006) 1.05
Role of lung epithelial cells in defense against Klebsiella pneumoniae pneumonia. Infect Immun (2002) 1.05
Contact-dependent protein secretion in Porphyromonas gingivalis. Infect Immun (1998) 1.05
Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus. Infect Immun (2014) 1.00
A murine model for infection with Burkholderia cepacia with sustained persistence in the spleen. Infect Immun (1999) 1.00
Biosynthesis and structure of the Burkholderia cenocepacia K56-2 lipopolysaccharide core oligosaccharide: truncation of the core oligosaccharide leads to increased binding and sensitivity to polymyxin B. J Biol Chem (2009) 0.98
A type IV secretion system contributes to intracellular survival and replication of Burkholderia cenocepacia. Infect Immun (2008) 0.97
Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia. J Bacteriol (2005) 0.96
Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients. J Clin Microbiol (2004) 0.95
Characterization of SodC, a periplasmic superoxide dismutase from Burkholderia cenocepacia. Infect Immun (2007) 0.93
Burkholderia cenocepacia J2315 escapes to the cytosol and actively subverts autophagy in human macrophages. Cell Microbiol (2013) 0.93
Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease. Infect Immun (2009) 0.90
Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro. Eur J Clin Microbiol Infect Dis (2007) 0.88
Clinical and environmental Burkholderia strains: biofilm production and intracellular survival. Curr Microbiol (2007) 0.86
A Burkholderia cepacia complex non-ribosomal peptide-synthesized toxin is hemolytic and required for full virulence. Virulence (2012) 0.85
Mechanisms of Disease: Host-Pathogen Interactions between Burkholderia Species and Lung Epithelial Cells. Front Cell Infect Microbiol (2015) 0.83
Transmissibility and infection control implications of Burkholderia cepacia in cystic fibrosis. Can J Infect Dis (1998) 0.83
Host evasion by Burkholderia cenocepacia. Front Cell Infect Microbiol (2012) 0.82
Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells. Eur J Clin Microbiol Infect Dis (2007) 0.82
Entry of Burkholderia organisms into respiratory epithelium: CFTR, microfilament and microtubule dependence. J Cyst Fibros (2009) 0.81
Infection of Burkholderia cepacia induces homeostatic responses in the host for their prolonged survival: the microarray perspective. PLoS One (2013) 0.81
Profiling of Burkholderia cepacia secretome at mid-logarithmic and early-stationary phases of growth. PLoS One (2011) 0.80
The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection. PLoS One (2014) 0.79
Similarity of gene expression patterns in human alveolar macrophages in response to Pseudomonas aeruginosa and Burkholderia cepacia. Infect Immun (2005) 0.79
Gentamicin delivery to Burkholderia cepacia group IIIa strains via membrane vesicles from Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother (2003) 0.77
Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex. Antimicrob Agents Chemother (2016) 0.75
Potential of metabolomics to reveal Burkholderia cepacia complex pathogenesis and antibiotic resistance. Front Microbiol (2015) 0.75
A novel method for investigating Burkholderia cenocepacia infections in patients with cystic fibrosis and other chronic diseases of the airways. BMC Microbiol (2016) 0.75
HOST IMMUNE RECOGNITION OF THE EPIDEMIC CYSTIC FIBROSIS PATHOGEN BURKHOLDERIA DOLOSA. Infect Immun (2017) 0.75
In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. Infect Immun (1987) 11.24
A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature (1985) 9.45
Cytoskeletal rearrangements accompanying salmonella entry into epithelial cells. J Cell Sci (1991) 4.18
Salmonella interactions with polarized human intestinal Caco-2 epithelial cells. J Infect Dis (1990) 4.09
Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science (1996) 3.38
Respiratory epithelial cell invasion by group B streptococci. Infect Immun (1992) 2.86
Interaction of Pseudomonas aeruginosa with A549 pneumocyte cells. Infect Immun (1991) 2.83
Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun (1994) 2.37
Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Clin Microbiol (1984) 2.23
Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J Bacteriol (1994) 2.21
Invasion and replication of Salmonella typhimurium in animal cells. Infect Immun (1990) 2.19
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
Bordetella parapertussis invasion of HeLa 229 cells and human respiratory epithelial cells in primary culture. Infect Immun (1989) 1.78
Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia. Infect Immun (1990) 1.73
Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J Infect Dis (1991) 1.68
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother (1983) 1.60
Cloning, sequence, and expression of a lipase gene from Pseudomonas cepacia: lipase production in heterologous hosts requires two Pseudomonas genes. J Bacteriol (1991) 1.52
Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis. Johns Hopkins Med J (1980) 1.47
Translocation of Campylobacter jejuni across human polarized epithelial cell monolayer cultures. J Infect Dis (1992) 1.37
Characterization of hemolysin in extracellular products of Pseudomonas cepacia. J Clin Microbiol (1987) 1.28
Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol (1988) 1.25
Acridine orange stain for determining intracellular enteropathogens in HeLa cells. J Clin Microbiol (1991) 1.17
Cellular antibiotic pharmacology. Semin Perinatol (1982) 1.06
Neutralizing monoclonal antibodies to an extracellular Pseudomonas cepacia protease. Infect Immun (1994) 0.97
On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun (1967) 18.32
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Maturation of the immune response in germinal centers. Cell (1991) 5.68
Why doesn't audit work? BMJ (1998) 5.63
Analytical gel isotachophoresis of proteins with carrier ampholyte spacers. Ann N Y Acad Sci (1973) 4.09
Private company wins rights to Icelandic gene database. BMJ (1999) 4.04
Mapping the active site of papain with the aid of peptide substrates and inhibitors. Philos Trans R Soc Lond B Biol Sci (1970) 3.29
On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. Biochem Biophys Res Commun (1968) 3.10
Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun (1997) 2.97
Respiratory epithelial cell invasion by group B streptococci. Infect Immun (1992) 2.86
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61
Silicon nanowire-based solar cells on glass: synthesis, optical properties, and cell parameters. Nano Lett (2009) 2.41
Detection of Herpes simplex virus DNA by real-time PCR. J Clin Microbiol (2000) 2.29
Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med (1997) 2.26
Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med (1984) 2.26
Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol (1999) 2.25
Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun (1996) 2.25
Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol (1998) 2.25
Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am J Pathol (2001) 2.18
The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med (1996) 2.11
Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest (1989) 2.09
Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol (1995) 2.09
A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J Clin Invest (1988) 2.04
Conformational studies of poly-L-alanine in water. Biopolymers (1968) 2.02
Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion. Infect Immun (1993) 2.01
A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology (2005) 2.00
Position-dependent accommodative shift of retropupillary fixated iris-claw lenses. Graefes Arch Clin Exp Ophthalmol (2012) 2.00
Two school epidemics. Br Med J (1966) 1.93
The interfascicular nerve-grafting of the median and ulnar nerves. J Bone Joint Surg Am (1972) 1.82
Freeze-fracture study of mast cell secretion. Proc Natl Acad Sci U S A (1976) 1.80
Pilonidal sinus disease. J Visc Surg (2013) 1.76
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer (2008) 1.75
New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1987) 1.75
Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J Infect Dis (1991) 1.68
Persistence of pedicle blood flow up to 10 years after free musculocutaneous tissue transfer. Plast Reconstr Surg (1998) 1.67
Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J Biol Chem (1995) 1.65
Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells. Infect Immun (1993) 1.63
Safety guidelines for use of nitric oxide. Lancet (1992) 1.62
On estimating recessive frequencies from truncated samples. Biometrics (1967) 1.62
Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry as a tool for rapid diagnosis of potentially toxigenic Corynebacterium species in the laboratory management of diphtheria-associated bacteria. Euro Surveill (2010) 1.60
Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol (2000) 1.59
Neonatal urinary uric acid/creatinine [correction of ceratinine] ratio as an additional marker of perinatal asphyxia. Eur J Pediatr (1995) 1.59
Cystic retroperitoneal lymphangiomas in adults. Eur J Surg Oncol (1997) 1.59
Transcytosis of gastrointestinal epithelial cells by Escherichia coli K1. Pediatr Res (2001) 1.57
Lithium dilution cardiac output measurement: a comparison with thermodilution. Crit Care Med (1997) 1.57
Stability of the Astronomical Frequencies Over the Earth's History for Paleoclimate Studies. Science (1992) 1.54
Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone. Eur Respir J (2004) 1.52
The purification of papain by affinity chromatography. Eur J Biochem (1970) 1.52
Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr (2000) 1.51
Eosinophil peroxidase-induced mast cell secretion. J Exp Med (1980) 1.51
High tie versus low tie vascular ligation of the inferior mesenteric artery in colorectal cancer surgery: impact on the gain in colon length and implications on the feasibility of anastomoses. Dis Colon Rectum (2012) 1.51
Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein. Antimicrob Agents Chemother (1992) 1.50
Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am J Respir Crit Care Med (1997) 1.49
Malignant degeneration in Madelung's disease (benign lipomatosis of the neck): case report. Br J Plast Surg (1983) 1.46
A case-control study of risk factors for intraoperative suprachoroidal expulsive hemorrhage. Ophthalmology (1991) 1.45
Hepatitis delta: on soft paws across Germany. Infection (2012) 1.43
Giant and reversible extrinsic magnetocaloric effects in La0.7Ca0.3MnO3 films due to strain. Nat Mater (2012) 1.43
Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. Am J Physiol (1999) 1.42
Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal. Int J Radiat Oncol Biol Phys (2001) 1.41
Differential antimicrobial activity of human mononuclear phagocytes against the human biovars of Chlamydia trachomatis. J Immunol (1987) 1.40
Profiling left and right ventricular proportional output during fetal life with a novel systolic index in the aortic isthmus. Ultrasound Obstet Gynecol (2014) 1.39
On the size of the active site in proteases. II. Carboxypeptidase-A. Biochem Biophys Res Commun (1967) 1.39
How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus? Infusionsther Transfusionsmed (1996) 1.39
Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Clin Invest (1997) 1.36
Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear. Proc Natl Acad Sci U S A (1990) 1.35
Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. AIDS (1999) 1.33
Ultrastructural study of Chlamydia trachomatis surface antigens by immunogold staining with monoclonal antibodies. Infect Immun (1987) 1.33
Taxol produces a predominantly sensory neuropathy. Neurology (1989) 1.32
Gram type-specific broad-range PCR amplification for rapid detection of 62 pathogenic bacteria. J Clin Microbiol (1999) 1.32
The fasciocutaneous supraclavicular artery island flap for releasing postburn mentosternal contractures. Plast Reconstr Surg (1997) 1.31
A nuclear mutant of Arabidopsis with impaired stability on distinct transcripts of the plastid psbB, psbD/C, ndhH, and ndhC operons. Plant Cell (1996) 1.28
Involvement of a pertussis toxin-sensitive G protein in the mitogenic signaling pathways of sphingosine 1-phosphate. J Biol Chem (1995) 1.27
Sleep-wake pattern in preterm infants under two different care schedules during four-day polygraphic recording. Neuropediatrics (1981) 1.27
Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med (2001) 1.26
Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system. J Exp Med (1981) 1.25
Abnormal mast cell granules in the beige (Chédiak-Higashi syndrome) mouse. J Histochem Cytochem (1975) 1.24
Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol (2001) 1.23
Ultrastructural characterization and morphometric analysis of human eosinophil degranulation. J Cell Sci (1985) 1.22
Inhibition of return in spatial attention: direct evidence for collicular generation. Nat Neurosci (1999) 1.21
Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta. Eur J Immunol (1991) 1.20
Macromolecular mechanisms of sputum inhibition of tobramycin activity. Antimicrob Agents Chemother (1995) 1.19
Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells In vitro. Infect Immun (1998) 1.19
Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat (2011) 1.18
Ultrastructural study of entry of Chlamydia strain TWAR into HeLa cells. Infect Immun (1988) 1.18
A treadmill ergometer for three-dimensional ground reaction forces measurement during walking. J Biomech (2001) 1.18
SNAP-23 is not cleaved by botulinum neurotoxin E and can replace SNAP-25 in the process of insulin secretion. J Biol Chem (1997) 1.17
QTL detection by multi-parent linkage mapping in oil palm (Elaeis guineensis Jacq.). Theor Appl Genet (2010) 1.17
Polymers tripeptides as collagen models. II. Conformational changes of poly(L-prolyl-glycyl-L-prolyl) in solution. J Mol Biol (1966) 1.16
A revolution in drug discovery. Combinatorial chemistry still needs logic to drive science forward. BMJ (2000) 1.14
Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J Immunol (2000) 1.13
The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats. J Infect Dis (1992) 1.13